Skip to main content
Fig. 4 | Journal of Hematology & Oncology

Fig. 4

From: Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives

Fig. 4

Functions of wild-type MLL, LSD1 and onco-MLL fusion proteins. a MLL methylates H3K4 and initiates RNA polymerase II (Pol II) mediated gene transcription, while LSD1 removes the methyl group from H3K4me1 and 2 and keeps a balanced H3K4 methylation; b The onco-MLL protein complex involving AF4, AF9, AF10, or ENL can recruit DOT1L, which methylates H3K79 and causes overexpression of leukemia-relevant genes

Back to article page